Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Cited by (538)

Items 201–300 of 538

1. Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design
   Shokouh Rezaei, Yahya Sefidbakht, Vuk Uskoković · 2021 · Briefings in Bioinformatics
2. Wastewater surveillance for SARS-CoV-2 in a small coastal community: Effects of tourism on viral presence and variant identification among low prevalence populations
   Andrew L. Rainey, Julia C. Loeb, Sarah E. Robinson, John A. Lednicky, John McPherson, Sue Colson, Michael J. Allen, Eric Stephen Coker, Tara Sabo‐Attwood, Anthony T. Maurelli et al. · 2021 · Environmental Research
3. The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro
   Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B. C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder · 2022 · Virologica Sinica
4. Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
   Shiho Tanaka, C. Anders Olson, Christopher O. Barnes, Wendy Higashide, Marcos R. Gonzalez, Justin D. Taft, Ashley Richardson, Marta Martín-Fernández, Dusan Bogunovic, Priyanthi N.P. Gnanapragasam et al. · 2022 · Cell Reports
5. Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
   Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes C. Hellmuth, Alexandra Hollaus, Anne‐Wiebe Mohr, Erik Gaitzsch, Tobias Weiglein, Enrico Georgi et al. · 2022 · Nature Communications
6. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey
   Katrina Lythgoe, Tanya Golubchik, Matthew D. Hall, Thomas House, Roberto Cahuantzi, George MacIntyre-Cockett, Helen R. Fryer, Laura Thomson, Anel Nurtay, Mahan Ghafari et al. · 2023 · Proceedings of the Royal Society B Biological Sciences
7. Dominant clade‐featured SARS‐CoV‐2 co‐occurring mutations reveal plausible epistasis: An in silico based hypothetical model
   A. S. M. Rubayet Ul Alam, Ovinu Kibria Islam, Md. Shazid Hasan, Mir Raihanul Islam, Shafi Mahmud, Hassan M. Al‐Emran, Iqbal Kabir Jahid, Keith A. Crandall, M. Anwar Hossain · 2021 · Journal of Medical Virology
8. Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations
   Antonino Di, Flávia Cunha, Nicola Petrosillo, Nicholas J. Beeching, Oner Ergonul, Eskild Petersen, Marion Koopmans · 2021 · Clinical Microbiology and Infection
9. Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
   Vivek Govind Kumar, Dylan S. Ogden, Ugochi H. Isu, Adithya Polasa, James Losey, Mahmoud Moradi · 2022 · Journal of Biological Chemistry
10. Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
    Narasimha Murthy Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan · 2022 · Reviews in Medical Virology
11. Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern
    Andrew E. Clark, Zhaohui Wang, Emily Ostman, Hui Zheng, Huiyu Yao, Brandi L. Cantarel, Mohammed Kanchwala, Chao Xing, Li Chen, Pei Irwin et al. · 2022 · Clinical Chemistry
12. Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
    Ralf Kircheis, Oliver Planz · 2022 · International Journal of Molecular Sciences
13. Molecular dynamics studies reveal structural and functional features of the SARS‐CoV‐2 spike protein
    Ludovico Pipitò, Roxana‐Maria Rujan, Christopher A. Reynolds, Giuseppe Deganutti · 2022 · BioEssays
14. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection
    Hans Verkerke, Gregory L. Damhorst, Daniel S. Graciaa, Kaleb Benjamin McLendon, William O’Sick, Chad J. Robichaux, Narayanaiah Cheedarla, Sindhu Potlapalli, Shang‐Chuen Wu, Kristin R V Harrington et al. · 2022 · The Journal of Infectious Diseases
15. Coordinated evolution at amino acid sites of SARS-CoV-2 spike
    Alexey D. Neverov, Gennady G. Fedonin, Anfisa V. Popova, Daria Bykova, Georgii A. Bazykin · 2023 · eLife
16. Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
    Simone Hoffmann, Eva Vanessa Schrezenmeier, Maxime Desmarets, Fabian Halleck, Antoine Dürrbach, Lynn Peters, Anna-Teresa Tremmel, Alina Seidel, Marita Führer, Friederike Bachmann et al. · 2025 · EBioMedicine
17. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India
    Pushpendra Singh, Kuldeep Kumar Sharma, Priyanka Singh, Anudita Bhargava, Sanjay Singh Negi, Pratibha Sharma, Mayuri Pramod Bhise, Manish Kumar Tripathi, Atul Jindal, Nitin Madhusudan Nagarkar · 2022 · Microbial Pathogenesis
18. SARS-CoV-2 Variants and Vaccination
    Yang Liu, Jianying Liu, Pei‐Yong Shi · 2022 · Zoonoses
19. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
    Valery A. Petrenko, James W. Gillespie, Laura Maria De Plano, Michael Shokhen · 2022 · Viruses
20. Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
    AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Pritha Ghosh, Rohit Suratekar, Abhishek Siroha, Dibyendu Roy Chowdhury, John Charles O’Horo, Joseph D. C. Yao, Bobbi S. Pritt et al. · 2021 · Research Square
21. COVID‐19: emergence and mutational diversification of SARS‐CoV‐2
    Harald Brüssow · 2021 · Microbial Biotechnology
22. Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications
    Michele Spinicci, Alessio Mazzoni, Marco Coppi, Alberto Antonelli, Lorenzo Salvati, Laura Maggi, Gregorio Basile, Lucia Graziani, Nicoletta Di Lauria, Vincenzo Di Pilato et al. · 2022 · Journal of Clinical Immunology
23. Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak
    Shenghui Weng, Jingzhe Shang, Ye‐Xiao Cheng, Hangyu Zhou, Chengyang Ji, Rong Yang, Aiping Wu · 2022 · Biosafety and Health
24. Spread of endemic SARS-CoV-2 lineages in Russia before April 2021
    Galya V. Klink, Ksenia R. Safina, Sofya K. Garushyants, Mikhail A. Moldovan, Elena Nabieva, Andrey B. Komissarov, Dmitry A. Lioznov, Georgii A. Bazykin · 2022 · PLoS ONE
25. The Comparison of Mutational Progression in SARS-CoV-2: A Short Updated Overview
    Abeer Asif, Iqra Ilyas, Mohammad Abdullah, Sadaf Sarfraz, Muhammad Mustafa, Arif Mahmood · 2022 · Journal of Molecular Pathology
26. Host Membranes as Drivers of Virus Evolution
    Mélanie Matveeva, Marine Lefebvre, Henri Chahinian, Nouara Yahi, Jacques Fantini · 2023 · Viruses
27. Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer
    Maresa C. Woodfield, Steven A. Pergam, Parth D. Shah · 2021 · Cancer
28. A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
    Damien Richard, Liam P. Shaw, Robert Lanfear, Russell B Corbett-Detig, Angie S. Hinrichs, Jakob McBroome, Yatish Turakhia, Mislav Acman, Christopher J. Owen, Cedric C.S. Tan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
29. SARS-CoV-2 Resistance to Small Molecule Inhibitors
    Uxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, Shahidul M. Islam · 2024 · Current Clinical Microbiology Reports
30. ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern
    Tsung-I Tsai, Jahan S. Khalili, Mark Gilchrist, Andrew B. Waight, Daniella Cohen, Zhuo Shi, Yong Zhang, Muran Ding, Hai Zhu, Amanda Nga-Sze Mak et al. · 2022 · Antiviral Research
31. Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection
    Arghavan Alisoltani, Lukasz Jaroszewski, Mallika Iyer, Arash Iranzadeh, Adam Godzik · 2022 · Frontiers in Genetics
32. On the Origins of Omicron’s Unique Spike Gene Insertion
    AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Rohit Suratekar, Bharathwaj Raghunathan, Michiel J.M. Niesen, Venky Soundararajan · 2022 · Vaccines
33. Intra-Host Evolution Provides for Continuous Emergence of SARS-CoV-2 Variants
    Justin T. Landis, Razia Moorad, Linda Pluta, Carolina Caro‐Vegas, Ryan P. McNamara, Anthony B. Eason, Aubrey Bailey, Femi Cleola S. Villamor, Angelica Juarez, Jason P. Wong et al. · 2021 · mBio
34. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases
    Rolf F. Barth, Louis Maximilian Buja, Alison L. Barth, David E. Carpenter, Anil Vasdev Parwani · 2021 · Archives of Pathology & Laboratory Medicine
35. T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components
    Lichen Jing, Xia Wu, Maxwell P. Krist, Tien-Ying Hsiang, Victoria Louise Campbell, Christopher L. McClurkan, Sydney M. Favors, Lawrence A. Hemingway, Charmie Godornes, Denise Q. Tong et al. · 2022 · JCI Insight
36. Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
    Mariele Montanari, Barbara Canonico, Evelyn Nordi, Daniela Vandini, Simone Barocci, Serena Benedetti, Eugenio Carlotti, Loris Zamai · 2021 · Advances in Biological Regulation
37. Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19
    Fatah Chérifi, Fatima Laraba‐Djebari · 2021 · The Protein Journal
38. A comparison of high-throughput SARS-CoV-2 sequencing methods from nasopharyngeal samples
    Zuzana Gerber, Christian Daviaud, Damien Delafoy, Florian Sandron, Enagnon Kazali Alidjinou, Jonathan Mercier, Sylvain Gerber, Vincent Meyer, Anne Boland, Laurence Bocket et al. · 2022 · Scientific Reports
39. Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants
    Zunlong Ke, Thomas P. Peacock, Jonathan C. Brown, Carol Sheppard, Tristan Ian Croll, Abhay Kotecha, Daniel H. Goldhill, William Barclay, John A. G. Briggs · 2024 · The EMBO Journal
40. Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?
    Taha Menasria, Jaime Aguilera · 2022 · Microorganisms
41. Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
    Kyle Wolf, Jason C. Kwan, Jeremy P. Kamil · 2022 · mBio
42. Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines
    Theron H. Gilliland, Yanan Liu, Rong Li, Matthew Dunn, Emily L. Cottle, Yutaka Terada, Zachary Ryckman, Maria D. H. Alcorn, Shauna N. Vasilatos, Jeneveve D. Lundy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
43. Wave-wise comparative genomic study for revealing the complete scenario and dynamic nature of COVID-19 pandemic in Bangladesh
    Ishtiaque Ahammad, Mohammad Uzzal Hossain, Anisur Rahman, Zeshan Mahmud Chowdhury, Arittra Bhattacharjee, Keshob Chandra Das, Chaman Ara Keya, M. Salimullah · 2021 · PLoS ONE
44. Hotspot Mutations in SARS-CoV-2
    Indrajit Saha, Nimisha Ghosh, Nikhil Sharma, Suman Nandi · 2021 · Frontiers in Genetics
45. Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status
    Paula Luize Camargos Fonseca, Filipe Romero Rebello Moreira, Rafael Marques de Souza, Natália R Guimarães, Nara de Oliveira Carvalho, Talita Adelino, Hugo José Alves, Luige Biciati Alvim, Darlan da Silva Cândido, Helena Perez Coelho et al. · 2022 · Virus Evolution
46. Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.
    2022 · PubMed Central
47. Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
    Sung Hee Ko, Pierce E. Radecki, Frida Belinky, Jinal N. Bhiman, Susan T. Meiring, Jackie Kleynhans, Daniel Gyamfi Amoako, Vanessa Guerra Canedo, Margaret Lucas, Dikeledi Kekana et al. · 2024 · Nature Communications
48. Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
    Susan R. Conway, Michael Daniel Keller, Catherine M. Bollard · 2022 · Blood
49. SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
    Raluca Dumache, Alexandra Enache, Ioana Gabriela Macasoi, Cristina Adriana Dehelean, Victor Cristian Dumitrascu, Alexandra Mihailescu, Roxana Popescu, Mihaela Vlad, Cristian Sebastian Vlad, Camelia Oana Mureşan · 2022 · Pathogens
50. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
    Manish Chandra Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy Miguel Ribeiro et al. · 2021 · medRxiv
51. Characterizing SARS-CoV-2 genome diversity circulating in South American countries: Signatures of potentially emergent lineages?
    Marina Muñoz, Luz Helena Patiño, Nathalia Ballesteros, Alberto Paniz‐Mondolfi, Juan David Ramírez · 2021 · International Journal of Infectious Diseases
52. Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein
    R. Shyama Prasad Rao, Nagib Ahsan, Chunhui Xu, Lingtao Su, Jacob C. Verburgt, Luca Fornelli, Daisuke Kihara, Dong He Xu · 2021 · Evolutionary Bioinformatics
53. Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy
    Carmela De Marco, Claudia Veneziano, Alice Massacci, Matteo Pallocca, Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Aida Giancotti, Luigia Gallo, Angelo Giuseppe Lamberti et al. · 2022 · Frontiers in Microbiology
54. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
    Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Davood Bashash · 2022 · International Immunopharmacology
55. Inactivation of two SARS-CoV-2 virus surrogates by electron beam irradiation on large yellow croaker slices and their packaging surfaces
    Zonghong Luo, Ke Ni, Yuancheng Zhou, Guanhong Chang, Jiangtao Yu, Chunling Zhang, Wenqi Yin, Dishi Chen, Shuwei Li, Shengyao Kuang et al. · 2022 · Food Control
56. Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles
    Mervat E. Hamdy, Ayman H. El‐Deeb, Naglaa Mohammed Hagag, Momtaz Abdelhady Shahein, Osama Alaidi, Hussein A. Hussein · 2023 · International Journal of Veterinary Science and Medicine
57. Comparative phylogenetic analysis of SARS-CoV-2 spike protein—possibility effect on virus spillover
    Abozar Ghorbani, Samira Samarfard, Neda Eskandarzade, Alireza Afsharifar, Mohammad Hadi Eskandari, Ali Niazi‎, K. Izadpanah, Thomas P. Karbanowicz · 2021 · Briefings in Bioinformatics
58. A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
    Adam Leach, F. Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma M. Bentley, Giada Mattiuzzo, Shimobi C. Onuoha, Ami Miller, Hanif Ali, Terence Howard Rabbitts · 2021 · Antiviral Research
59. Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection
    Dominik Sebastian Nörz, Moritz Grunwald, Hui Ting Tang, Flaminia Olearo, Thomas Günther, Alexis Robitaille, Nicole Fischer, Adam T. Grundhoff, Martin Aepfelbacher, Susanne Pfefferle et al. · 2021 · Diagnostics
60. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential
    Slawomir Kubik, Nils Arrigo, Jaume Bonet, Zhenyu Xu · 2021 · Viruses
61. The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad‐Spectrum Anti‐Coronavirus Drugs
    Shen H. Tan, Martin G. Banwell, Wen‐Cai Ye, Ping Lan, Lorenzo V. White · 2022 · Chemistry - An Asian Journal
62. De novo emergence of SARS‐CoV‐2 spike mutations in immunosuppressed patients
    Lacy M. Simons, Egon Anderson Ozer, Stéphanie Gambut, Taylor J. Dean, Li Zhang, Pavan P. Bhimalli, Jeffrey R. Schneider, João I. Mamede, Michael G. Ison, Reem Karmali et al. · 2022 · Transplant Infectious Disease
63. Independent acquisition of short insertions at the RIR1 site in the spike N‐terminal domain of the SARS‐CoV‐2 BA.2 lineage
    Samuele Greco, Marco Gerdol · 2022 · Transboundary and Emerging Diseases
64. Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
    Xiao Niu, Zhiqiang Li, Jing Wang, Fanchong Jian, Yuanling Yu, Weiliang Song, Ayijiang Yisimayi, Shuo Du, Zhiying Zhang, Qianran Wang et al. · 2024 · Emerging Microbes & Infections
65. Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
    Marta Ribes, Carlos Chaccour, Gemma Moncunill · 2021 · Signal Transduction and Targeted Therapy
66. Emergence of Progressive Mutations in SARS-CoV-2 From a Hematologic Patient With Prolonged Viral Replication
    Carolina García‐Vidal, María Iglesias‐Caballero, Pedro Puerta‐Alcalde, Vicente Más, Genoveva Cuesta, Nicole García-Pouton, Sarai Varona, Francisco Pozo, Sonia Vázquez‐Morón, María Ángeles Marcos et al. · 2022 · Frontiers in Microbiology
67. COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient
    Ryo Morita, Ritsuko Kubota‐Koketsu, Xiuyuan Lu, Tadahiro Sasaki, Emi E. Nakayama, Yu‐Chen Liu, Daisuke Okuzaki, Daisuke Motooka, James B. Wing, Yasunori Fujikawa et al. · 2023 · iScience
68. Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
    Xiaodi Yu, Jarek Juraszek, Lucy Rutten, Mark J. G. Bakkers, Sven Blokland, Jelle M. Melchers, Niels J. F. van den Broek, Annemiek Verwilligen, Pravien D. Abeywickrema, Johan Vingerhoets et al. · 2023 · PLoS Pathogens
69. Evolution of transient RNA structure–RNA polymerase interactions in respiratory RNA virus genomes
    Charlotte V. Rigby, Kimberly R. Sabsay, Karishma Bisht, Dirk Eggink, Hamid Jalal, Aartjan J.W. te Velthuis · 2023 · Virus Evolution
70. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
71. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19
    Jesús Zepeda–Cervantes, Daniel Martínez-Flores, Josué O. Ramírez‐Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis A. Vaca, Rosa Elena Sarmiento Silva · 2022 · Viruses
72. SARS‐CoV‐2 variants and spike mutations involved in second wave of COVID‐19 pandemic in India
    Radhakrishna Muttineni, Binitha R.N., Kalyani Putty, Kavitha Marapakala, Sandra KP, Jaslin Panyam, Vemula Aravind, Shashi Mohan Singh, Subin Balachandran, Viroji Rao S.T. et al. · 2022 · Transboundary and Emerging Diseases
73. SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1
    Ana Paula Muterle Varela, Janira Prichula, Fabiana Quoos Mayer, Richard Steiner Salvato, Fernando Hayashi Sant’Anna, Tatiana Schäffer Gregianini, Letícia Garay Martins, Adriana Seixas, Ana Beatriz Gorini da Veiga · 2021 · Infection Genetics and Evolution
74. Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective
    Anushree Sinha, Satyam Sangeet, Susmita Roy · 2023 · ACS Omega
75. Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
    Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi · 2024 · Vaccines
76. Current Updates on Variants of SARS‐CoV‐ 2: Systematic Review
    Mulat Erkihun, Bayu Ayele, Zelalem Asmare, Kirubel Endalamaw · 2024 · Health Science Reports
77. Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
    Laurence S. C. Lok, Shuvam Sarkar, Calista Chi In Lam, C. Law, Sin Teng Chau, Chun Yip Thomas Leung, Wai Hin Cheang, Ting Li, Olivia Monteiro, Daniel Tomas Baptista‐Hon · 2024 · MedComm – Future Medicine
78. Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications
    Zeyu Sun, Xiaoqin Zheng, Feiyang Ji, Menghao Zhou, Xiaoling Su, Keyi Ren, Lanjuan Li · 2021 · Infectious Microbes & Diseases
79. Recent highlights on Omicron as a new SARS-COVID-19 variant: evolution, genetic mutation, and future perspectives
    Pooja Khairnar, Mukesh Soni, Mayank Handa, Yassine Riadi, Prashant Kesharwani, Rahul Shukla · 2022 · Journal of drug targeting
80. The phylodynamics of SARS-CoV-2 during 2020 in Finland
    Phuoc Truong Nguyen, Ravi Kant, Frederik Van den Broeck, Maija T. Suvanto, Hussein Alburkat, Jenni M. E. Virtanen, Ella Ahvenainen, Robert S. Castrén, Samuel Leandro Hong, Guy Baele et al. · 2022 · Communications Medicine
81. Human interaction targets of SARS-CoV-2 spike protein: A systematic review
    Seyed Nooreddin Faraji, Mohammad Javad Raee, Seyed Mohamad Ali Hashemi, Gholamreza Daryabor, Reza Tabrizi, Fateme Sadat Dashti, Emad Behboudi, Kamran Heidarnejad, Peyman Nowrouzi‐Sohrabi, Gholamreza Hatam · 2022 · European Journal of Inflammation
82. Network analysis uncovers the communication structure of SARS-CoV-2 spike protein identifying sites for immunogen design
    Pedro D. Manrique, Srirupa Chakraborty, Rory C. Henderson, Robert J. Edwards, Rachael A. Mansbach, Kien Nguyen, Victoria Stalls, Carrie Saunders, Katayoun Mansouri, Priyamvada Acharya et al. · 2022 · iScience
83. Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient
    Martina Brandolini, Silvia Zannoli, Giulia Gatti, Valentina Arfilli, Monica Cricca, Giorgio Dirani, Agnese Denicolò, Simona Semprini, Laura Grumiro, Manuela Imola et al. · 2023 · Viruses
84. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape
    Marco Antônio M. Pretti, Rômulo Gonçalves Agostinho Galvani, Nicole de Miranda Scherer, Alessandro S. Farias, Mariana Boroni · 2022 · Infection Genetics and Evolution
85. A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
    Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael Patrick Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
86. Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
    Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, Maria Alexandrou, Antonia Aristokleous, Christina Christodoulou, Ioanna Gregoriou, Marios Ioannides, Olga Kalakouta, Christos Karagiannis et al. · 2022 · Viruses
87. Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation
    Pedro Miguel Carneiro Jerônimo, Cleber Furtado Aksenen, Igor Oliveira Duarte, Roberto Dias Lins, Fábio Miyajima · 2023 · Journal of Virology
88. Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
    Michael Schöfbänker, Theresa Günther, Eva Ulla Lorentzen, Marie-Luise Romberg, Marc Tim Hennies, Rieke Neddermeyer, Marlin Maybrit Müller, Alexander Mellmann, Chiara Robin Bojarzyn, Georg Lenz et al. · 2024 · PLoS Pathogens
89. Antigen transfer from non-APCs to APCs impacts the efficacy and safety of protein- and mRNA- based vaccines
    Yingying Shi, Yichao Lu, Bing Qin, Mengshi Jiang, Xuemeng Guo, Xiang Olivia Li, Yu Liu, Jiaxin Huang, Junlei Zhang, Zhenyu Luo et al. · 2021 · Nano Today
90. The Informative Nature of the Disappeared SARS-CoV-2 Genomic Sequences: A Mini-review with Perspectives
    Amgad M. Rabie · 2022 · Advanced Chemicobiology Research
91. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach
    Patil Pranita Uttamrao, Chakkarai Sathyaseelan, L. Ponoop Prasad Patro, Thenmalarchelvi Rathinavelan · 2021 · Frontiers in Immunology
92. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia
    Wasfi Farès, Kaïs Ghedira, Mariem Gdoura, Anissa Chouikha, S Boubaker, Marwa Khedhiri, Kaouthar Ayouni, Asma Lamari, Henda Touzi, Walid Hammemi et al. · 2021 · Microbiology Spectrum
93. Epitope mapping of neutralising anti‐SARS‐CoV‐2 monoclonal antibodies: Implications for immunotherapy and vaccine design
    Somayeh Ghotloo, Faezeh Maghsood, Forough Golsaz‐Shirazi, Mohammad Mehdi Amiri, Christiane Moog, Fazel Shokri · 2022 · Reviews in Medical Virology
94. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
    Vidya Niranjan, Anagha Shamsundar Setlur, K. S. Chandrashekar, Akshay Uttarkar, Kalavathi Murugan Kumar, Sinosh Skariyachan · 2022 · Structural Chemistry
95. Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients
    Yan Leyfman, Nancy Emmanuel, Gayathri Pramil Menon, Muskan Joshi, William B. Wilkerson, Jared Cappelli, Timothy K. Erick, Chandler Howard Park, Pushpa Sharma · 2023 · Journal of Hematology & Oncology
96. Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
    Hyung‐Joon Kwon, Martina Košíková, Weichun Tang, Uriel Ortega‐Rodriguez, Peter Radvák, Ruoxuan Xiang, Kelly E. Mercer, Levan Muskhelishvili, Kelly Davis, Jerrold Michael Ward et al. · 2022 · iScience
97. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era
    Ender Volkan · 2021 · Molecular Biotechnology
98. SARS-CoV-2 Virology
    Yijia Li, Jonathan Z. Li · 2022 · Infectious Disease Clinics of North America
99. Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
    Anna Foix, Daniel López, Francisco Díez‐Fuertes, Michael J. McConnell, Antonio J. Martín-Galiano · 2022 · PLoS Computational Biology
100. Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD
     Antonia Sophia Peter, Eva Grüner, Eileen Socher, Kirsten Fraedrich, Elie Richel, Sandra M. Mueller-Schmucker, Arne Cordsmeier, Armin Ensser, Heinrich Sticht, Klaus Überla · 2022 · International Journal of Molecular Sciences